This is a routine administrative filing with no new financial information. The real story is the complete leadership and board turnover, plus the two recent related-party acquisitions (Zorro Net and DR. Frucht) that suggest a pivot away from the original phage therapy business. Monitor the Q1 2026 10-Q for the first financial results under the new management and the impact of these acquisitions on revenue and cash burn.
Price Chart
Executive Summary
BiomX filed Amendment No. 1 to its 2025 10-K solely to add Part III items (directors, executive compensation, security ownership, related transactions, and auditor fees) that were omitted from the original filing. This is a routine administrative amendment — no financial restatements, no auditor changes, and no new financial data. The filing also includes Section 302 certifications from the new CEO and CFO, and discloses a complete board and management overhaul that occurred in Q1 2026.
Key Facts
- Amendment adds Part III items (10-14) that were previously omitted; no financial restatements or corrections.
- Entire prior management team resigned: CEO Jonathan Solomon (March 4, 2026), CFO Marina Wolfson (Feb 24, 2026), CDO Dr. Merav Bassan (Feb 24, 2026).
- New CEO Michael Oster and CFO David Rokach appointed; entire board replaced between Jan-Mar 2026.
- Prior board members (7 total) all resigned between Feb 9 and March 4, 2026; new board of 4 directors appointed.
- Director Amir Shalom resigned April 29, 2026 after only 55 days on the board.
- Company completed two related-party acquisitions in April 2026: Zorro Net Ltd. from Water IO Ltd. (1.3M shares + $1.25M note) and 60% of DR. Frucht Systems Ltd. from Mandragola Ltd. ($750K cash + $3M convertible note + 923K shares + warrants).
- Auditor remains Kesselman & Kesselman (PwC Israel); audit fees unchanged at $190K for both 2025 and 2024.
- 10,111,516 shares outstanding as of April 30, 2026; market cap ~$4M.
- CEO and CFO surrendered shares for cancellation on April 24, 2026 (10,000 and 5,000 shares respectively), now hold zero shares.
Financial Impact
No financial data in this amendment; the original 10-K financials are unchanged.
Risk Factors
- Complete management and board turnover in Q1 2026 raises governance and strategic continuity concerns.
- Director Amir Shalom's resignation after only 55 days without explanation is a red flag.
- Related-party acquisitions (Water IO, Mandragola) with interlocking director relationships create conflict-of-interest risk.
- Company has a $4M market cap with significant dilution potential from outstanding warrants and convertible notes.
- Historical performance shows 0% win rate on prior reports with massive negative returns (-84% avg T+20).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001213900-26-050373 |
| Document: ea028831201ex31-2.htm | 0001213900-26-050373 |
| Document: ea028831201ex31-1.htm | 0001213900-26-050373 |
| Document: 0001213900-26-050373-index-headers.html | 0001213900-26-050373 |
| Document: 0001213900-26-050373-index.html | 0001213900-26-050373 |
| Document: 0001213900-26-050373.txt | 0001213900-26-050373 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $0.1425 $1.85 | ▲ +1198.25% | ▲ +1199.20% | $0.3600 (+152.63%) |
Aug 28, 2026 5w ago | 8-K | $0.1371 $0.1550 | ▲ +13.06% | ▲ +13.20% | $0.3600 (+162.58%) |
Aug 5, 2026 8w ago | Press Release | $0.1800 $0.1483 | ▲ +17.61% | ▲ +17.96% | $0.3600 (−100.00%) |
Jul 28, 2026 9w ago | 8-K | $0.1834 $0.1868 | ▼ −1.85% | ▲ +0.42% | $0.3600 (−96.29%) |
Jul 28, 2026 9w ago | Press Release | $0.1834 $0.1868 | ▼ −1.85% | ▲ +0.42% | $0.3600 (−96.29%) |
Jul 27, 2026 9w ago | 424B5 | $0.1834 $0.1868 | ▼ −1.85% | ▲ +0.42% | $0.3600 (−96.29%) |
Jul 8, 2026 12w ago | Press Release | $0.2758 $0.2100 | ▼ −23.86% | ▼ −24.72% | $0.3600 (+30.53%) |
Jul 2, 2026 13w ago | 8-K | $0.3190 $0.2800 | ▲ +12.23% | ▲ +13.16% | $0.3600 (−12.85%) |
Jun 29, 2026 13w ago | S-1 | $0.3478 $0.3020 | ▲ +13.17% | ▲ +13.77% | $0.3600 (−3.51%) |
Jun 22, 2026 14w ago | DEFA14A | $0.4615 $0.3590 | ▼ −22.21% | ▼ −23.22% | $0.3600 (−21.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access